Author: News Room

Genius Group Limited Our Five-Year Roadmap: $280M to $2B Capital plan is designed to maximize Net Asset Value per Ordinary Share (NAVPS) and minimize dilution to ordinary shareholders by utilizing perpetual preferred capital, a funding method adopted by treasury companies with over $16 billion raised since January 2025. Five-year capital plan designed to fund board-approved targets of $800 million AI Treasury and $827 million Bitcoin Treasury with $2 billion in total assets by FY2031. Capital plan follows significant re-pricing within Company’s AI Treasury. Look-through investments within the Company’s AI Treasury including Anthropic, Anduril and Databricks have re-priced 100% to 154%…

Descrease article font size Increase article font size The union representing American air traffic controllers has acknowledged allegations that two members left work early shortly before an Air Canada regional jet crashed at LaGuardia Airport in March, killing two pilots. U.S. media reports suggest the Federal Aviation Administration is looking to fire the two flight controllers, who allegedly clocked out roughly an hour before their shift ended, leaving a pair of colleagues at the LaGuardia tower without backup.The National Air Traffic Controllers Association confirmed the allegations, first reported by the Wall Street Journal on Thursday, in an emailed statement.“NATCA is…

Approval of LISRAYA™ (brepocitinib) marks a significant scientific and clinical milestone for people living with this rare autoimmune neuromuscular disease. FDA Approves First Targeted Therapy for Dermatomyositis FDA approves first targeted therapy for people living with dermatomyositis. New York, Aug. 27, 2026 (GLOBE NEWSWIRE) — The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration’s approval of LISRAYA™ (brepocitinib), developed and marketed by Priovant Therapeutics, as the first targeted therapy specifically approved to treat adults living with dermatomyositis. The approval represents an important advance for a disease that has historically relied on broad immunosuppressive therapies rather than treatments developed to address…

Neurosurgeons in London, England, have successfully completed the first-ever operation to remove a brain tumour using AI assistance, U.K. health officials confirmed. The operation, which restored the eyesight of a 48-year-old man, took place at the National Hospital for Neurology and Neurosurgery, part of the University College London Hospital’s NHS Foundation Trust, in a clinical trial using AI technology developed at University College London. Details of the trial were kept under wraps until the patient, Rhys Hibbert, made a full recovery.Hibbert, a customer services manager and community volunteer from the outskirts of London, is the first patient to undergo surgery…

CTC Providing Functional and Technical Cyber Services for Facility-Related Control Systems (FRCS) Program CTC Advises on FRCS, Ensuring Resilient and Secure Infrastructure CTC operational technology specialists advise Marine Corps personnel on best practices and cybersecurity strategies for facility-related control systems, ensuring resilient and secure infrastructure. Johnstown, PA, Aug. 27, 2026 (GLOBE NEWSWIRE) — Marine Corps Installations Command (MCICOM) Government Facilities (GF) has awarded Concurrent Technologies Corporation (CTC) a $14.9 million contract to deliver Operational Technology (OT) functional and technical cyber services in support of the MCICOM Facility-Related Control Systems (FRCS) Cyber Services Program. This competitively bid contract continues CTC’s longstanding…

The memory limitations were first introduced with Android 17, appearing first on Pixel phones. It’s probably no coincidence that the base configurations of the Pixel 11 Pro and 11 Pro XL come with less RAM than last year’s models. As Android 17 rolls out to the wider ecosystem, Google warns developers that they’ll need to play nice with a much bigger range of devices: “Over the coming year, an increasing number of manufacturers will leverage the Android per-app memory limits across their portfolio of device RAM configurations from 4GB to 16GB+ devices.”Google has a pretty clear directive if apps misbehave:…

The Anniversary Issue celebrates four decades of Arhaus while the new Fall 2026 Collection introduces a bold exploration of color and materiality alongside the brand’s new Made-to-Order Stone program BOSTON HEIGHTS, Ohio, Aug. 27, 2026 (GLOBE NEWSWIRE) — Arhaus (NASDAQ: ARHS), a leader in artisan-crafted and responsibly sourced home furnishings, today announced the launch of its Fall 2026 Collection, featured in The Anniversary Issue celebrating the brand’s 40th anniversary. The collection reflects four decades of artisan partnerships, global sourcing, and enduring craftsmanship while continuing to push the brand’s assortment forward. Richly figured woods, expressive natural stone, saturated upholstery, and unexpected…

DigitalC named Broadband Provider of the Year and Customer Experience Award winner; CEO Joshua Edmonds receives Broadband Visionary Award in a record year for one of the industry’s leading national awards programs A National Spotlight on DigitalC and Community-Based Broadband A milestone moment for DigitalC at the 2026 Broadband Communities Summit. DigitalC earned three national honors: Broadband Provider of the Year, Customer Experience Award and Broadband Visionary Award for CEO Joshua Edmonds. The recognition reflects the strength of a community-based broadband model built to scale, perform and deliver the connectivity experience residents deserve. Cleveland, Ohio, Aug. 27, 2026 (GLOBE NEWSWIRE)…

LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune diseaseLISRAYA is a once-daily pill that directly targets key immune pathways implicated in dermatomyositis pathogenesisLISRAYA demonstrated robust efficacy on multiple measures of DM disease activity, accompanied by substantial steroid-sparing benefits, in the largest dermatomyositis clinical trial ever conductedLISRAYA is available immediately in the U.S.Eligible patients may pay as little as $0 per month through the LISRAYA My Compass Support program.Roivant will host an investor call to discuss these updates tomorrow, August 28, 2026, at 8:00 a.m. ET. BASEL, Switzerland and LONDON and…

Akash Palkhiwala Akash Palkhiwala joins Applied Materials’ Board of Directors SANTA CLARA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced the appointment of Akash Palkhiwala to serve on its board of directors. As Chief Financial Officer and Chief Operating Officer of Qualcomm Incorporated, Mr. Palkhiwala brings extensive financial and operational leadership experience in the computing and technology industry. Mr. Palkhiwala has also been appointed to the board’s Audit Committee. “Akash is a terrific addition to our board of directors,” said Tom Iannotti, Chairman of the Board. “His track record of leadership in finance and decades of experience…